Page last updated: 2024-10-26

disopyramide and Acute Disease

disopyramide has been researched along with Acute Disease in 14 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day."9.05Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980)
"Patients with acute myocardial infarction admitted to a coronary care unit were given either intravenous and oral disopyramide or matching placebo on admission and throughout their hospital stay."9.05Intravenous and oral disopyramide after myocardial infarction. ( Barnes, PC; Haybyrne, T; Nicholls, DP, 1980)
"Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days."9.04Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977)
"The incidence of ventricular arrhythmias after myocardial infarction was compared in a double blind study of disopyramide (33 patients), aprindine (34 patients) and placebo (31 patients)."9.04Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction. ( Chaudron, JM; Pouleur, H; Reyns, P, 1977)
"Twenty-six patients with clinically significant ventricular arrhythmias were randomly assigned to treatment with either intravenous disopyramide or lidocaine; crossover to the other agent was permitted in nine cases of primary drug failure."9.04Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial. ( Fozzard, HA; Rawling, DA; Sbarbaro, JA, 1979)
"The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure."7.66Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981)
"Disopyramide, a new anti-arrhythmic drug, has been assessed in twenty-one episodes of cardiac arrhythmia secondary to acute ischaemic heart disease which failed to respond to more conventional suppressive therapy with lignocaine and other standard drugs."7.65The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease. ( Sandler, G, 1977)
"Flecainide was as effective as the combination of digoxin and disopyramide and it acted significantly faster and was associated with fewer relapses."6.66Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. ( Campbell, TJ; Gavaghan, TP; Kelly, RP; Koegh, AM; Morgan, JJ; Thorburn, C, 1988)
"473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day."5.05Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980)
"Patients with acute myocardial infarction admitted to a coronary care unit were given either intravenous and oral disopyramide or matching placebo on admission and throughout their hospital stay."5.05Intravenous and oral disopyramide after myocardial infarction. ( Barnes, PC; Haybyrne, T; Nicholls, DP, 1980)
"Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days."5.04Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977)
"The incidence of ventricular arrhythmias after myocardial infarction was compared in a double blind study of disopyramide (33 patients), aprindine (34 patients) and placebo (31 patients)."5.04Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction. ( Chaudron, JM; Pouleur, H; Reyns, P, 1977)
"Twenty-six patients with clinically significant ventricular arrhythmias were randomly assigned to treatment with either intravenous disopyramide or lidocaine; crossover to the other agent was permitted in nine cases of primary drug failure."5.04Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial. ( Fozzard, HA; Rawling, DA; Sbarbaro, JA, 1979)
"The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure."3.66Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981)
"Disopyramide, a new anti-arrhythmic drug, has been assessed in twenty-one episodes of cardiac arrhythmia secondary to acute ischaemic heart disease which failed to respond to more conventional suppressive therapy with lignocaine and other standard drugs."3.65The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease. ( Sandler, G, 1977)
"Flecainide was as effective as the combination of digoxin and disopyramide and it acted significantly faster and was associated with fewer relapses."2.66Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. ( Campbell, TJ; Gavaghan, TP; Kelly, RP; Koegh, AM; Morgan, JJ; Thorburn, C, 1988)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-199011 (78.57)18.7374
1990's3 (21.43)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilcox, RG1
Rowley, JM1
Hampton, JR1
Mitchell, JR1
Roland, JM1
Banks, DC1
Nicholls, DP1
Haybyrne, T1
Barnes, PC1
De Backer, M1
Stoupel, E1
Kahn, RJ1
Jaeger, A1
Sauder, P1
Tempe, JD1
Mantz, JM1
Accornero, F1
Pellanda, A1
Ruffini, C1
Bonelli, S1
Latini, R1
Kishikawa, T1
Maruyama, T1
Kaji, Y1
Sasaki, Y1
Kanaya, S1
Fujino, T1
Niho, Y1
Ishihara, Y1
Sakai, Y1
Hayashi, Y1
Tomobuchi, Y1
Hano, T1
Nishio, I1
Zainal, N1
Carmichael, DJ1
Griffiths, JW1
Besterman, EM1
Kidner, PH1
Gillham, AD1
Summers, GD1
Pouleur, H1
Chaudron, JM1
Reyns, P1
Story, JR1
Abdulla, AM1
Frank, MJ1
Sbarbaro, JA1
Rawling, DA1
Fozzard, HA1
Sandler, G1
Gavaghan, TP1
Koegh, AM1
Kelly, RP1
Campbell, TJ1
Thorburn, C1
Morgan, JJ1

Trials

8 trials available for disopyramide and Acute Disease

ArticleYear
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
    Lancet (London, England), 1980, Oct-11, Volume: 2, Issue:8198

    Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Disopyra

1980
Intravenous and oral disopyramide after myocardial infarction.
    Lancet (London, England), 1980, Nov-01, Volume: 2, Issue:8201

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Di

1980
Effects of oral repetitive loading of disopyramide on acute-onset atrial fibrillation with concurrent monitoring of serum drug concentration.
    International journal of cardiology, 1999, Volume: 68, Issue:1

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disop

1999
Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Lancet (London, England), 1977, Oct-29, Volume: 2, Issue:8044

    Topics: Acute Disease; Administration, Oral; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram

1977
Anti-dysrhythmic treatment in acute myocardial infarction.
    Lancet (London, England), 1979, Jan-27, Volume: 1, Issue:8109

    Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind

1979
Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    European journal of cardiology, 1977, Volume: 5, Issue:5

    Topics: Acute Disease; Adult; Aged; Aprindine; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide;

1977
Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    The American journal of cardiology, 1979, Volume: 44, Issue:3

    Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Injections

1979
Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass.
    British heart journal, 1988, Volume: 60, Issue:6

    Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Clin

1988

Other Studies

6 other studies available for disopyramide and Acute Disease

ArticleYear
Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    European journal of clinical pharmacology, 1981, Volume: 19, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; C

1981
[Acute voluntary or accidental disopyramide poisoning. A multicentric study of 106 cases (author's transl)].
    La Nouvelle presse medicale, 1981, Oct-03, Volume: 10, Issue:35

    Topics: Acute Disease; Brain Diseases; Cardiovascular Diseases; Disopyramide; Humans; Pyridines; Time Factor

1981
Prolonged cardiopulmonary resuscitation during acute disopyramide poisoning.
    Veterinary and human toxicology, 1993, Volume: 35, Issue:3

    Topics: Acute Disease; Adolescent; Cardiopulmonary Resuscitation; Disopyramide; Drug Overdose; Electrocardio

1993
Dynamic outflow obstruction due to the transient extensive left ventricular wall motion abnormalities caused by acute myocarditis in a patient with hypertrophic cardiomyopathy: reduction in ventricular afterload by disopyramide.
    Japanese circulation journal, 1999, Volume: 63, Issue:8

    Topics: Acute Disease; Aged; Cardiomyopathy, Hypertrophic; Coronary Angiography; Disopyramide; Echocardiogra

1999
Cardiogenic shock and disopyramide phosphate.
    JAMA, 1979, Aug-17, Volume: 242, Issue:7

    Topics: Acute Disease; Arrhythmias, Cardiac; Cardiac Output; Disopyramide; Heart Failure; Humans; Kidney Fai

1979
The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    The Journal of international medical research, 1977, Volume: 5, Issue:5

    Topics: Acute Disease; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Pyridines

1977